Related by context. Frequent words. (Click for all words.) 62 EPIX Pharmaceuticals Inc. 60 Healthnostics Inc. 59 Biosite Incorporated 59 Schedules Fiscal 58 Q2 Loss Narrows 58 Hold Fourth Quarter 58 Inc. NASDAQ MRNA 58 VIA Pharmaceuticals 58 Cardium Therapeutics Inc. 57 RegeneRx Biopharmaceuticals Inc. 57 ARYx Therapeutics Inc. 57 Maxim Pharmaceuticals 57 Nasdaq VRTX 57 Q3 Loss Narrows 57 ISTA Pharmaceuticals 56 Nasdaq ASTM 56 Q1 Loss Narrows 56 Host Second Quarter 56 Regains Compliance With 56 Schedules Fourth Quarter 56 Inc. NasdaqGM 56 IMPAX Laboratories Inc. 56 Q2 Loss Widens 56 Immunomedics Inc. 56 Electro Optical Sciences 56 AMAG Pharmaceuticals 55 Files Annual Report 55 NASDAQ BPAX 55 Hybridon 55 Corporation NASDAQ GENZ 55 Rigel Pharmaceuticals 55 Nasdaq AMLN 55 Genaera Corporation 55 Novelos Therapeutics Inc. 55 Threshold Pharmaceuticals Inc. 55 Inc. Nasdaq NVAX 55 Sunesis Pharmaceuticals Inc. 55 Generex Biotechnology Corp. 55 CEO Exercises Options 55 Threshold Pharmaceuticals 55 Q4 Loss Narrows 55 NASDAQ SHPGY 55 Oxigene 55 Updates Guidance 55 Webcast Annual Meeting 55 Enzon Pharmaceuticals 55 Adeona Pharmaceuticals Inc. 55 GTXI 55 ICON plc 54 Schedules Second Quarter 54 Neose Technologies Inc. 54 Host Third Quarter 54 Bearish Pressure Building 54 Nasdaq REGN 54 Schedules Third Quarter 54 ENZN 54 CuraGen Corporation 54 Q3 Loss Widens 54 NovaBay Pharmaceuticals Inc. 54 Targeted Genetics Corporation 54 Cerus Corporation 54 Lipid Sciences Inc. 54 Host Fourth Quarter 54 MGI PHARMA INC. 54 filed Solicitation Recommendation 54 Barrier Therapeutics Inc. 54 NASDAQ IMCL 54 AVANIR Pharmaceuticals 54 Inc. F#Q# Qtr 54 Rexahn Pharmaceuticals Inc. 54 Guides FY# Quick Facts 54 Molecular Insight Pharmaceuticals 54 http:/www.primenewswire.com/newsroom/prs/?pkgid=#Muntu 54 Director Exercises Options 54 Q4 Loss Widens 53 Holds Annual Meeting 53 Alseres Pharmaceuticals Inc. 53 AVANT Immunotherapeutics Inc. 53 CoTherix Inc. 53 BioSpecifics Technologies Corp. 53 Regains Compliance 53 CEO Discusses Q1 53 Inovio Biomedical Corporation 53 F#Q# Qtr End 53 Progenics Pharmaceuticals 53 NASDAQ AMAG 53 NASDAQ ARIA 53 http:/cts.businesswire.com/ct/CT?id=smartlink&urlAND EVEN 53 Stockholders Approve Merger 53 Inc. Nasdaq DSCO 53 Company NASDAQ MDCO 53 Releases Third Quarter 53 Finalizes Acquisition 53 SciClone Pharmaceuticals 53 www.labopharm.com 53 Genelabs Technologies Inc. 53 Q1 Loss Widens 53 DVAX 53 EMERYVILLE Calif. BUSINESS WIRE 53 www.schering plough.com 53 Cytori Therapeutics NASDAQ CYTX